ethylenediamine has been researched along with arabinogalactan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, H; Li, X; Pei, F; Wang, X; Xiao, Y; Xue, R; You, T | 1 |
1 other study(ies) available for ethylenediamine and arabinogalactan
| Article | Year |
|---|---|
Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Topics: Animals; Cell Survival; Contrast Media; Ethylenediamines; Galactans; Glycoconjugates; Hepatocytes; Heterocyclic Compounds; Humans; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rats; Rats, Wistar | 2014 |